Midwest Biomedical Accelerator Consortium (MBArC)

Information

The Midwest Biomedical Accelerator Consortium (MBArC) is a program designed to provide funding, training, and education to academic researchers. The accelerator aims to foster innovation and development in the biomedical field by supporting researchers with the necessary resources and guidance to bring their ideas to fruition. Entrepreneurs and researchers benefit from MBArC through financial support, expert mentorship, and educational workshops that help them navigate the complexities of biomedical research and commercialization.

How to Apply

To apply for the Midwest Biomedical Accelerator Consortium (MBArC), interested researchers and entrepreneurs should visit the program's official website. The application process typically involves submitting a detailed proposal outlining the research project, its potential impact, and how the funding will be utilized. Applicants may also need to provide background information about their team, previous research, and any preliminary data supporting their project's feasibility. Once submitted, applications are reviewed by a panel of experts who evaluate the project's potential for success and alignment with MBArC's goals.

Total number of startups invested: 2

Average Funding: Information not provided

Industry: Biomedical research and development

Market: United States

Other Accelerators/VC/Investors

RBL_START

RBL_START is an accelerator program focusing on investing in cybersecurity startups. It aims to support innovative companies in the cybersecurity sector by providing them with the necessary resources,...

View

IMPACT Accelerator

IMPACT Accelerator's mission is to help entrepreneurs, enterprises, and institutions in their transformation to become competitive in the digital era. The accelerator provides a robust support system ...

View

Plan H Ventures

Plan H Ventures is an investment company that focuses on investing in businesses across various stages of growth. Entrepreneurs who collaborate with Plan H Ventures can expect not only financial suppo...

View